Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mayumi Nakagawa

Concepts (204)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
14
2019
157
5.420
Why?
Human papillomavirus 16
11
2021
51
4.390
Why?
Papillomavirus Vaccines
7
2021
66
4.010
Why?
Uterine Cervical Neoplasms
8
2021
285
3.090
Why?
Oncogene Proteins, Viral
11
2011
59
2.980
Why?
Papillomaviridae
7
2019
106
2.830
Why?
Repressor Proteins
9
2011
170
2.480
Why?
Epitopes, T-Lymphocyte
7
2018
32
2.330
Why?
Cancer Vaccines
3
2021
102
1.910
Why?
T-Lymphocytes
6
2021
334
1.690
Why?
Candida
4
2018
61
1.640
Why?
CD8-Positive T-Lymphocytes
6
2018
111
1.620
Why?
Cervix Uteri
3
2021
54
1.060
Why?
Cervical Intraepithelial Neoplasia
2
2015
42
1.030
Why?
Immunity, Cellular
4
2013
85
0.890
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
80
0.870
Why?
Langerhans Cells
3
2018
11
0.860
Why?
Epitopes
2
2015
84
0.860
Why?
Neoplasms
2
2021
1158
0.830
Why?
Viral Load
2
2019
87
0.800
Why?
Cell Cycle Checkpoints
1
2019
34
0.780
Why?
HLA Antigens
4
2006
52
0.760
Why?
Health Education
1
2021
190
0.750
Why?
CD4-Positive T-Lymphocytes
3
2018
190
0.680
Why?
Adult
19
2021
14064
0.640
Why?
Plasma Exchange
2
2014
33
0.620
Why?
Health Knowledge, Attitudes, Practice
1
2021
546
0.610
Why?
Humans
37
2021
51226
0.600
Why?
Cross Protection
1
2015
6
0.600
Why?
T-Lymphocytes, Regulatory
2
2016
86
0.600
Why?
Colposcopy
1
2015
19
0.580
Why?
Interleukin-12
2
2018
35
0.580
Why?
Adjuvants, Immunologic
2
2018
64
0.570
Why?
Immunity, Innate
1
2015
108
0.550
Why?
Female
25
2021
28342
0.550
Why?
Lectins, C-Type
1
2013
30
0.540
Why?
Interferon-gamma
2
2012
196
0.540
Why?
Health
1
2013
29
0.540
Why?
Papillomavirus E7 Proteins
8
2018
35
0.540
Why?
Patient Selection
1
2015
293
0.500
Why?
Afibrinogenemia
1
2012
5
0.500
Why?
Enzyme-Linked Immunospot Assay
1
2012
2
0.490
Why?
T-Lymphocytes, Cytotoxic
4
2009
76
0.480
Why?
Young Adult
8
2021
4171
0.480
Why?
Middle Aged
13
2021
13329
0.460
Why?
Plateletpheresis
1
2010
8
0.440
Why?
Warts
1
2010
23
0.440
Why?
Antigens, Fungal
1
2010
30
0.440
Why?
Blood Preservation
1
2010
31
0.430
Why?
Dermatitis
1
2010
37
0.430
Why?
Cell Proliferation
5
2021
1120
0.420
Why?
Blood Proteins
1
2010
102
0.420
Why?
Anaphylaxis
1
2010
70
0.410
Why?
Telemedicine
1
2015
398
0.390
Why?
Antigens, Viral
2
2009
54
0.380
Why?
Human papillomavirus 18
1
2008
10
0.370
Why?
Cells, Cultured
5
2021
1828
0.370
Why?
Immunotherapy
1
2010
243
0.370
Why?
Blood Platelets
1
2010
302
0.350
Why?
Vaccinia virus
1
2007
7
0.340
Why?
Host-Pathogen Interactions
2
2021
151
0.340
Why?
Dendritic Cells
1
2008
148
0.340
Why?
Immunophenotyping
1
2007
128
0.330
Why?
Immunoenzyme Techniques
1
2007
173
0.330
Why?
Isoantibodies
1
2004
34
0.290
Why?
Neoplasm Grading
2
2021
132
0.280
Why?
Lead
1
2004
34
0.280
Why?
Cell Line, Tumor
5
2021
1476
0.280
Why?
Infant, Very Low Birth Weight
1
2004
53
0.280
Why?
Neutropenia
1
2004
116
0.280
Why?
DNA, Viral
3
2011
151
0.260
Why?
Blood Transfusion
1
2004
126
0.260
Why?
High-Throughput Nucleotide Sequencing
2
2021
194
0.250
Why?
Aged
8
2021
10169
0.250
Why?
Capsid Proteins
1
2002
24
0.250
Why?
Early Detection of Cancer
2
2021
130
0.240
Why?
Antibody Formation
1
2002
65
0.240
Why?
Adolescent
5
2021
6735
0.240
Why?
Genes, T-Cell Receptor
1
2021
4
0.240
Why?
Clone Cells
3
2007
87
0.240
Why?
Clinical Trials, Phase I as Topic
1
2021
30
0.230
Why?
Remission Induction
1
2021
218
0.220
Why?
Left-Right Determination Factors
1
2020
1
0.220
Why?
Cystadenocarcinoma, Serous
1
2021
70
0.220
Why?
Nodal Protein
1
2020
3
0.220
Why?
Vaginal Smears
2
2011
31
0.220
Why?
Videotape Recording
1
2021
35
0.220
Why?
Cytokines
2
2016
683
0.220
Why?
Pilot Projects
2
2021
775
0.220
Why?
Treatment Outcome
3
2021
5480
0.220
Why?
Lymphocyte Activation
1
2021
213
0.220
Why?
Amino Acid Sequence
3
2008
761
0.210
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
309
0.200
Why?
Metagenome
1
2019
49
0.200
Why?
Feasibility Studies
1
2021
399
0.200
Why?
Glioblastoma
1
2020
81
0.200
Why?
Health Behavior
1
2021
270
0.180
Why?
Up-Regulation
1
2020
528
0.180
Why?
Dose-Response Relationship, Drug
2
2016
1556
0.180
Why?
Multiple Myeloma
1
2012
2714
0.180
Why?
HLA-B Antigens
2
2008
7
0.180
Why?
Leukocytes, Mononuclear
2
2016
136
0.170
Why?
DNA
1
2021
565
0.170
Why?
Brain Neoplasms
1
2020
249
0.170
Why?
Bacteria
1
2019
229
0.170
Why?
Ovarian Neoplasms
1
2021
441
0.160
Why?
Age Factors
1
2021
1246
0.160
Why?
Histocompatibility Antigens Class II
2
2008
42
0.160
Why?
Cell Line
2
2012
1215
0.160
Why?
Vaccines, Subunit
1
2016
21
0.160
Why?
Male
8
2021
27647
0.160
Why?
Head and Neck Neoplasms
1
2019
310
0.150
Why?
Adaptive Immunity
1
2015
38
0.150
Why?
Leukocyte Count
2
2004
82
0.140
Why?
Chromatography, Liquid
1
2016
240
0.140
Why?
Molecular Sequence Data
2
2008
971
0.140
Why?
Tandem Mass Spectrometry
1
2016
241
0.140
Why?
Factor VIII
1
2014
23
0.140
Why?
Vaccination
1
2016
189
0.140
Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
18
0.140
Why?
ADAM Proteins
1
2014
26
0.140
Why?
Antigens, CD1
1
2013
8
0.140
Why?
Peptides
2
2006
280
0.140
Why?
Mannose-Binding Lectins
1
2013
10
0.140
Why?
Receptors, Pattern Recognition
1
2013
5
0.140
Why?
Proteome
1
2016
168
0.140
Why?
Indicators and Reagents
1
2013
58
0.140
Why?
Intracellular Space
1
2013
30
0.140
Why?
Skin Tests
1
2013
57
0.140
Why?
Time Factors
1
2021
3392
0.130
Why?
Cadherins
1
2013
78
0.130
Why?
Proteomics
1
2016
314
0.130
Why?
Communication
1
2015
260
0.120
Why?
Research Design
1
2015
348
0.120
Why?
Rural Health Services
1
2015
200
0.120
Why?
Socioeconomic Factors
1
2015
629
0.120
Why?
Antigens, CD
1
2013
264
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
699
0.120
Why?
Longitudinal Studies
2
2005
684
0.110
Why?
Injections, Intralesional
1
2010
40
0.110
Why?
Isotonic Solutions
1
2010
23
0.110
Why?
Platelet Transfusion
1
2010
34
0.110
Why?
P-Selectin
1
2010
45
0.110
Why?
Sodium Chloride
1
2010
62
0.110
Why?
Platelet Aggregation
1
2010
90
0.110
Why?
Platelet Activation
1
2010
65
0.100
Why?
Hypersensitivity
1
2010
65
0.100
Why?
HLA-A Antigens
1
2008
14
0.090
Why?
Antigen Presentation
1
2008
25
0.090
Why?
Immunologic Memory
1
2008
31
0.090
Why?
Histocompatibility Antigens Class I
1
2008
44
0.090
Why?
Polymerase Chain Reaction
1
2010
532
0.090
Why?
DNA, Recombinant
1
2007
18
0.090
Why?
African Americans
1
2013
711
0.090
Why?
Genes, MHC Class I
1
2006
11
0.080
Why?
Signal Transduction
2
2020
1812
0.080
Why?
Binding, Competitive
1
2006
133
0.080
Why?
Arkansas
1
2013
2146
0.080
Why?
Retrospective Studies
2
2010
5788
0.080
Why?
Animals
2
2019
14412
0.080
Why?
Calgranulin B
1
2005
7
0.070
Why?
Calgranulin A
1
2005
9
0.070
Why?
Neoplasm Staging
1
2008
799
0.070
Why?
Immunomagnetic Separation
1
2004
10
0.070
Why?
Epitope Mapping
1
2004
13
0.070
Why?
Risk Factors
1
2013
3924
0.070
Why?
Phosphorylation
2
2020
624
0.060
Why?
Sensitivity and Specificity
1
2005
960
0.060
Why?
Tumor Virus Infections
1
2002
44
0.060
Why?
Antibodies, Viral
1
2002
87
0.060
Why?
Lactobacillus
1
2021
8
0.060
Why?
SOX Transcription Factors
1
2021
4
0.060
Why?
Immunoglobulin G
1
2002
214
0.060
Why?
Cytodiagnosis
1
2021
43
0.060
Why?
Neuroendocrine Cells
1
2021
11
0.060
Why?
Biological Specimen Banks
1
2021
25
0.060
Why?
Cobalt
1
2020
15
0.060
Why?
Cytoplasm
1
2021
111
0.060
Why?
Vulnerable Populations
1
2020
40
0.050
Why?
Cell Hypoxia
1
2020
92
0.050
Why?
Epithelial-Mesenchymal Transition
1
2020
54
0.050
Why?
Neoplastic Stem Cells
1
2021
102
0.050
Why?
Recurrence
1
2002
690
0.050
Why?
Community Health Workers
1
2020
52
0.050
Why?
Cohort Studies
1
2004
1485
0.050
Why?
Cell Movement
1
2021
303
0.050
Why?
Multivariate Analysis
1
2021
688
0.050
Why?
Sequence Analysis, DNA
1
2019
259
0.050
Why?
Cell Survival
1
2020
687
0.050
Why?
Immunity, Humoral
1
2018
22
0.050
Why?
Cell Differentiation
1
2021
749
0.040
Why?
Phenotype
1
2021
814
0.040
Why?
Models, Biological
1
2021
846
0.040
Why?
Infant, Newborn
1
2004
2740
0.040
Why?
Mass Screening
1
2020
370
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2020
880
0.040
Why?
Prognosis
1
2021
2077
0.040
Why?
Autoantibodies
1
2014
122
0.030
Why?
Immunosuppressive Agents
1
2014
252
0.030
Why?
Combined Modality Therapy
1
2014
703
0.030
Why?
Mice, Inbred C57BL
1
2018
2029
0.030
Why?
Mice
1
2018
6254
0.020
Why?
Casein Kinase II
1
2005
11
0.020
Why?
Cell Division
1
2005
367
0.020
Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description